Article information
Full text is only aviable in PDF
Bibliografía
[1.]
D.S. Sitar, C.P. Warren, F.Y. Aoki.
Pharmacokinetics and pharmacokinetics of bambuterol, a long acting bronchodilator prodrug of terbutaline, in young an elderly patiens with asthma.
Clin Pharmacol Ther, 52 (1992), pp. 297-306
[3.]
U. Bang, J. Viby Morgensen, J.E. Wiren.
The effect of bambuterol (carbamilated terbutaline) on plasma cholinstesase activity and suxametonium-induced neuromuscular blockade in genotipically normal patients.
Acta Anaesthesiol Scand, 34 (1990), pp. 596-599
[4.]
A. Tunek, E. Hjertberg, J.V. Mogensen.
Interactions of bambuterol with human serum cholinesterase of the genotypes EuEu.
EaEa and EuEa. Biochem Famracol, 41 (1991), pp. 345-348
[5.]
A. Tunek, L.A. Svensson.
Bambuterol a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterase in human blood.
Drug Metab Dispos, 16 (1988), pp. 759-764
[6.]
S. Tan, I.P. Hall, J. Dewar, E. Dow, B. Lipworth.
Association between (β2-adrenoreceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics.
Lancet, 350 (1997), pp. 995-999
Copyright © 1999. Sociedad Española de Neumología y Cirugía Torácica
